Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-1 of 1
Keywords: PTX (Paclitaxel®)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells
Available to PurchaseAlessandro Prinetti, Danilo Millimaggi, Sandra D'Ascenzo, Matilda Clarkson, Arianna Bettiga, Vanna Chigorno, Sandro Sonnino, Antonio Pavan, Vincenza Dolo
Journal:
Biochemical Journal
Biochem J (2006) 395 (2): 311–318.
Published: 28 March 2006
...Alessandro Prinetti; Danilo Millimaggi; Sandra D'Ascenzo; Matilda Clarkson; Arianna Bettiga; Vanna Chigorno; Sandro Sonnino; Antonio Pavan; Vincenza Dolo PTX (Paclitaxel®) is an antimitotic agent used in the treatment of a number of major solid tumours, particularly in breast and ovarian cancer...
